STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
50
13F, latest reported quarter
What the filings say about LMNR
Insiders, 180 days
-$77.3K net sold
1 seller · 33% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$51.9K
1 notice
Limoneira insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Limoneira CO insiders sold a net $77.3K of stock across 47 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Sep 1, 2026.
The trade is 1.2% of the 84,812 shares held after it.
No other insider sold within 30 days.
50 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, CFO and Treasurer Hamm Gregory C. sold about $11.9K of LMNR under a 10b5-1 plan on Oct 1, 2026; 50 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Aug 3, 2026.
The trade is 1.2% of the 85,812 shares held after it.
No other insider sold within 30 days.
50 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, CFO and Treasurer Hamm Gregory C. sold about $13.8K of LMNR under a 10b5-1 plan on Sep 1, 2026; 50 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
LMNR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Hamm Gregory C.
Filed 2026-08-03
$51.9K
LMNR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
FULLERTHALER BEHAVIORAL MICRO-CAP EQUITY FUND
$273.7K position · as of 2026-06-30
0.9%
TETON Westwood Mighty Mites Fund
$1.5M position · as of 2026-06-30
0.7%
Gabelli Global Mini Mites Fund
$131.3K position · as of 2026-06-30
0.5%
Acuitas Small Cap Active ETF
$378.4K position · as of 2026-06-30
0.4%
Columbia Variable Portfolio - Small Cap Value Discovery Fund
$861.5K position · as of 2026-06-30
0.2%
Columbia Small Cap Value Discovery Fund
$4.7M position · as of 2026-07-31
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Harold Edwards
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.3M
$412.9K
$742.8K
+12%
+8%
2024
$2.5M
$4.3M
$1.5M
+100%
+24%
2023
$3.7M
$3.7M
$2.2M
+10%
+16%
2022
$2.0M
$1.3M
$866.9K
-10%
+33%
2021
$1.3M
$1.5M
$761.9K
+19%
+17%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $77.3K sold by insiders over 180 days, 50 funds added last quarter, $51.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$128.8M
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM LMNR
FY Oct 2025
$159.7M
FY Oct 2024
$191.5M
FY Oct 2023
$179.9M
FY Oct 2022
$184.6M
FY Oct 2021
$166.0M
Jul 2026
$43.8M
Apr 2026
$23.9M
Jan 2026
$18.2M
Oct 2025
$42.8M
Jul 2025
$47.5M
Apr 2025
$35.1M
Jan 2025
$34.3M
Oct 2024
$43.9M
At each fiscal year end
Single quarter
Net margin, TTM
-33.0%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM LMNR
FY Oct 2025
-10.0%
FY Oct 2024
+4.0%
FY Oct 2023
+5.2%
FY Oct 2022
-0.1%
FY Oct 2021
-2.1%
Jul 2026
-6.8%
Apr 2026
-89.5%
Jan 2026
-51.8%
Oct 2025
-20.3%
Jul 2025
-1.8%
Apr 2025
-9.6%
Jan 2025
-9.0%
Oct 2024
-4.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$31.0M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM LMNR
FY Oct 2025
-$19.5M
FY Oct 2024
$8.4M
FY Oct 2023
-$26.2M
FY Oct 2022
$4.8M
FY Oct 2021
-$229.0K
Jul 2026
-$3.8M
Apr 2026
-$9.5M
Jan 2026
-$14.8M
Oct 2025
-$3.0M
Jul 2025
-$6.1M
Apr 2025
$6.5M
Jan 2025
-$17.0M
Oct 2024
$3.9M
At each fiscal year end
Single quarter
Debt to equity
0.67x
long-term 2026-07-31 plus current 2026-07-31; equity 2026-07-31
Debt to equity LMNR
FY Oct 2025
0.40x
FY Oct 2024
0.21x
FY Oct 2023
0.22x
FY Oct 2022
0.58x
FY Oct 2021
0.70x
Jul 2026
0.67x
Apr 2026
0.62x
Jan 2026
0.53x
Oct 2025
0.40x
Jul 2025
0.35x
Apr 2025
0.30x
Jan 2025
0.31x
Oct 2024
0.21x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.15x
TTM operating cash flow over long-term 2026-07-31 plus current 2026-07-31
Cash flow to debt LMNR
FY Oct 2025
-0.08x
FY Oct 2024
0.44x
FY Oct 2023
-0.39x
FY Oct 2022
0.14x
FY Oct 2021
0.07x
Jul 2026
-0.15x
Apr 2026
-0.19x
Jan 2026
-0.05x
Oct 2025
-0.08x
Jul 2025
-0.01x
Apr 2025
0.49x
Jan 2025
0.26x
Oct 2024
0.44x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-25.7%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity LMNR
FY Oct 2025
-8.6%
FY Oct 2024
+4.0%
FY Oct 2023
+5.1%
FY Oct 2022
-0.1%
FY Oct 2021
-1.8%
Jul 2026
-25.7%
Apr 2026
-24.1%
Jan 2026
-12.5%
Oct 2025
-8.6%
Jul 2025
-4.9%
Apr 2025
-0.9%
Jan 2025
+4.4%
Oct 2024
+4.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-14.2%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets LMNR
FY Oct 2025
-5.2%
FY Oct 2024
+2.6%
FY Oct 2023
+2.8%
FY Oct 2022
-0.1%
FY Oct 2021
-0.9%
Jul 2026
-14.2%
Apr 2026
-13.7%
Jan 2026
-7.3%
Oct 2025
-5.2%
Jul 2025
-3.0%
Apr 2025
-0.5%
Jan 2025
+2.7%
Oct 2024
+2.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital LMNR
FY Oct 2025
n/a
FY Oct 2024
-1.7%
FY Oct 2023
+3.2%
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
-0.9%
Oct 2024
-1.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-16.9%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed LMNR
FY Oct 2025
-7.5%
FY Oct 2024
-2.3%
FY Oct 2023
+3.6%
FY Oct 2022
+0.6%
FY Oct 2021
-1.8%
Jul 2026
-16.9%
Apr 2026
-16.4%
Jan 2026
-9.2%
Oct 2025
-7.5%
Jul 2025
-4.4%
Apr 2025
-0.9%
Jan 2025
-1.4%
Oct 2024
-2.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing LMNR
FY Oct 2025
n/a
FY Oct 2024
67.47x
FY Oct 2023
29.77x
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
56.24x
Oct 2024
67.47x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value LMNR
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-16.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield LMNR
FY Oct 2025
-7.7%
FY Oct 2024
+1.8%
FY Oct 2023
-10.2%
FY Oct 2022
+2.3%
FY Oct 2021
-0.1%
Jul 2026
-13.2%
Apr 2026
-14.4%
Jan 2026
-6.6%
Oct 2025
-7.7%
Jul 2025
-4.8%
Apr 2025
+5.5%
Jan 2025
+0.9%
Oct 2024
+1.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing LMNR
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
LMNR ranks highest on risk and compliance (48th percentile) and institutional and government (38th), and lowest on growth (23rd), among Agriculture peers.
Profitability
30
Inputs
Return on equity-25.7% · 27 pct, universe of 3,863
Return on assets-14.2% · 31 pct, universe of 4,810
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-16.9% · 32 pct, universe of 3,236
Financial health
32
Inputs
Debt to equity0.67x · 37 pct, universe of 3,589
Cash flow to debt-0.15x · 27 pct, universe of 3,315
Growth
23
Inputs
Revenue growth, YoY-17.3% · 23 pct, sector of 31
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
31
Inputs
Net Form 4 buying (codes P and S), 180d-$52K · 63 pct, universe of 3,403
Insider buyers, 180d0 · 0 pct, universe of 3,445
Institutional and government
38
Inputs
Funds adding, latest quarter50 · 38 pct, universe of 4,971
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
48
Inputs
Short interest, % of float+5.8% · 24 pct, sector of 34
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+7.4% · 71 pct, universe of 3,661
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
LMNR filings, in plain words
Are Limoneira insiders buying or selling LMNR?
In the 180 days to 2026-10-28, Limoneira insiders were net sellers, a net $77.3K across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of LMNR?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $51.9K of stock; the latest, by Hamm Gregory C., was filed 2026-08-03.
Read the full summary
In the 180 days to 2026-10-28, Limoneira insiders were net sellers of LMNR, a net $77.3K across purchases and sales reported on Form 4 by 1 seller. 33% of the 6 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $51.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.